The challenge of assessing invasive biomarkers for epilepsy surgery
Brain
.
2024 Aug 1;147(8):e52-e54.
doi: 10.1093/brain/awae164.
Authors
Nicolas Roehri
1
,
Serge Vulliemoz
1
2
,
Stanislas Lagarde
1
3
4
Affiliations
1
EEG and Epilepsy Unit, University Hospitals and Faculty of Medicine, University of Geneva, CH-1211 Geneva, Switzerland.
2
Center for Biomedical Imaging (CIBM), Lausanne and Geneva, 1015 Lausanne, Switzerland.
3
APHM, Timone Hospital, Epileptology and Cerebral Rhythmology, 13005 Marseille, France.
4
Aix Marseille Univ, INSERM, INS, Inst Neurosci Syst, 13005 Marseille, France.
PMID:
38753681
PMCID:
PMC11292892
DOI:
10.1093/brain/awae164
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers*
Epilepsy* / surgery
Humans
Neurosurgical Procedures
Substances
Biomarkers
Grants and funding
SNSF_/Swiss National Science Foundation/Switzerland
LFCE
PHOCEO